Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)

Market Cap	3.54B -7.3%
Revenue (ttm)	1.15B -21.1%
Net Income	136.81M -4.5%
EPS	0.82 -4.7%
Shares Out	167.44M
PE Ratio	25.89
Forward PE	17.09
Dividend	0.30 (1.42%)
Ex-Dividend Date	Jun 11, 2025

Volume	4,131,622
Average Volume	3,295,856
Open	20.59
Previous Close	20.69
Day's Range	20.46 - 21.23
52-Week Range	20.24 - 40.19
Beta	0.75
RSI	37.25
Earnings Date	Apr 25, 2026

About SHA:688687

Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhizin tablets, capsules, and injections; and pirfenidone tablets for mild to moderate idiopathic pulmonary fibrosis. It is also involved in contract manuf...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 600
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688687

Financial Performance

In 2024, SHA:688687's revenue was 1.23 billion, a decrease of -12.87% compared to the previous year's 1.41 billion. Earnings were 142.37 million, an increase of 22.18%.